Cancer

Category

OneOncology and Foundation Medicine Unveil First-of-its-Kind Partnership to Advance Personalized Medicine at Community Oncology Practices

Foundation Medicine, Inc. and OneOncology announced today, August 17th, 2020, a new joint initiative that is intended to better enable OneOncology partner practice physicians to unlock the potential of precision oncology through comprehensive genomic profiling (CGP)...

OneOncology Expands to Southern California with the Los Angeles Cancer Network Joining the Platform for a Win-Win

OneOncology incorporated yet another community oncology provider, Los Angeles Cancer Network (LACN), into its growing network nationwide. This private equity-based group is developing an important model. OneOncology, on the one hand, seeks to embrace the realities of...

Cedric the Entertainer & SUTC Promote Research Awareness to Minority Populations Disproportionately Impacted by Cancer

Stand Up to Cancer (SU2C), a non-profit organization out of Hollywood entertainment world that supports cancer research, recently teamed with Cedric the Entertainer to bring more awareness of cancer research to People of Color, including African Americans. The star of...

NCI Renews Huntsman Cancer Institute Prestigious Designated Comprehensive Cancer Center Status: $29m & Near Perfect Ranking

Huntsman Cancer Institute (HCI) actually provides cancer research to nearly 20% of the lower 48 states of America, meaning that those that live in a massive section of the Intermountain West, from Wyoming, Montana and Idaho to Utah, eastern Nevada and western...

The Loss of Logan Must Lead to A Greater Commitment to R&D into Pediatric Diffuse Intrinsic Pontine Glioma (“DIPG”)

More funding needs to go into pediatric diffuse intrinsic pontine glioma or “DIPG,” an untreatable brain cancer. When stories of three-year old children losing their life to such a condition surface, TrialSite News springs to action directing supporters to the family...

Top Oncology Investigator Dr. Anthony Tolcher (Next Oncology) Selected by Heat Biologics to Lead Novel Phase I Oncology Study

Anthony Tolcher, MD, FRCPC, a medical oncologist and co-founder of research organization NEXT Oncology has been appointed the lead investigator for a Phase I clinical trial investigating Heat Biologics’ investigational therapy called PTX-35, a novel potential...